Dorsey & Whitney Trust’s Evolent Health EVH Stock Holding History

Dorsey & Whitney Trust’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-11,802	Closed	-$148K	–	411
2019 Q1	$148K	Buy	+11,802	New	+$187K	0.02%	381
2018 Q4	–	Sell	-9,086	Closed	-$258K	–	388
2018 Q3	$258K	Buy	+9,086	New	+$217K	0.04%	322

Other funds holding EVH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

ECP

Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Dorsey & Whitney Trust's EVH Position: Q2 2019 in Review

Dorsey & Whitney Trust sold out of Evolent Health (EVH) in Q2 2019, closing a stake of 11,802 shares — an estimated $148K sold.

Dorsey & Whitney Trust first reported a position in EVH in Q3 2018 and held it in 2 quarters. The position peaked at $258K in Q3 2018. 183 funds tracked by Wall St. Rank hold EVH as of Q2 2019.

Dorsey & Whitney Trust reported no remaining Evolent Health position as of Q2 2019 after selling out during the quarter.
Dorsey & Whitney Trust sold 11,802 Evolent Health shares in Q2 2019, an estimated $148K.
Dorsey & Whitney Trust first reported a position in Evolent Health in Q3 2018 and held it in 2 quarters.
Dorsey & Whitney Trust's Evolent Health position peaked at $258K in Q3 2018.
183 funds tracked by Wall St. Rank held Evolent Health as of Q2 2019.

Based on Dorsey & Whitney Trust's 13F filing for Q2 2019, filed 13 Aug 2019.